TELA Bio, Inc. provided revenue guidance for the full year 2024. Full year 2024 revenue is projected to range from $74.0 million to $76.0 million, representing growth of 27% to 30% over full year 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.49 USD | -4.47% | -14.48% | -32.18% |
06-04 | TELA Bio, Inc. Appoints Jeffrey Blizard to its Board of Directors | CI |
05-20 | TELA Bio, Inc. Appoints Greg Firestone as Chief Commercial Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.18% | 111M | |
-6.24% | 180B | |
-6.39% | 98.89B | |
-5.97% | 66.26B | |
-9.61% | 44.61B | |
+8.84% | 44.02B | |
+9.25% | 40.12B | |
+12.69% | 29.19B | |
+13.05% | 23.41B | |
-7.83% | 23.64B |
- Stock Market
- Equities
- TELA Stock
- News TELA Bio, Inc.
- TELA Bio, Inc. Provides Revenue Guidance for the Full Year 2024